Ignite Creation Date:
2025-12-24 @ 3:45 PM
Ignite Modification Date:
2026-01-12 @ 8:09 PM
Study NCT ID:
NCT00469092
Status:
COMPLETED
Last Update Posted:
2017-02-23
First Post:
2007-05-03
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Comparison of Biphasic Insulin Aspart 30 Versus Insulin Glargine Both in Combination With Metformin and Glimepiride in Subjects With Type 2 Diabetes
Sponsor:
Novo Nordisk A/S
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-05
Start Date Type:
None
Primary Completion Date:
2008-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-04
Completion Date Type:
ACTUAL
First Submit Date:
2007-05-03
First Submit QC Date:
None
Study First Post Date:
2007-05-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2009-11-30
Results First Submit QC Date:
None
Results First Post Date:
2010-01-06
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-01-05
Last Update Post Date:
2017-02-23
Last Update Post Date Type:
ACTUAL